Here, we revealed that emodin treatment enhanced anti-tumor effects in an H22 subcutaneous tumor-bearing mice model by increasing CD8+ T cell infiltration and promoting TNF-α, IFN-γ, and Gzms-B secretion. This evidence concerns the gene TNF and neoplasm.